(4S)-4-hydroxy-L-isoleucineFinding
(4S)-4-hydroxy-L-isoleucine decreases tumour necrosis factor alpha concentration
lowersInsufficient evidenceFinding
01 · The sentence it was drawn from
“In addition, inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFα), were assessed, and their serum and testis concentrations were found to be reduced in 4-HIL treated mice compared to those in HFD mice (Supplementary Figures S2C, D).”
(4S)-4-hydroxy-L-isoleucine
Tumour necrosis factor alpha concentration
lowers
- Who
- male C57BL/6 mice with high-fat-diet-induced obesity, high-fat diet continued in both arms
- Dose studied
- 4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection for six weeks; control HFD mice received saline injections
Insufficient evidencePMID 40917356 · 2025
02 · The study
- Study
- animal · not in humans
- Duration
- 6 weeks
Evidence, by strength
- strong
- moderate
- limited
- very limited
- insufficientthis finding
03 · The paper
Frontiers in endocrinology04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7EX6QB2H9XQ20STMDW3D93P